TGFbeta Antagonizes IFNgamma-Mediated Adaptive Immune Evasion via Activation of the AKT-Smad3-SHP1 Axis in Lung Adenocarcinoma. Ye F, Cai Z, Wang B, Zeng C, et al. Cancer Res 2023;83:2262-2277.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ye F, Cai Z, Wang B, Zeng C, et al. TGFbeta Antagonizes IFNgamma-Mediated Adaptive Immune Evasion via Activation of the AKT-Smad3-SHP1 Axis in Lung Adenocarcinoma. Cancer Res 2023;83:2262-2277.
PMID: 37145144